Elevance Health Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 36 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 398.38.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Elevance Health Inc is 4.84, ranking 74 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 49.75B, representing a year-over-year increase of 9.47%, while its net profit experienced a year-over-year increase of 30.86%.
Key Metrics
The current valuation score of Elevance Health Inc is 6.88, ranking 42 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 13.76, which is 49.30% below the recent high of 20.55 and 15.57% above the recent low of 11.62.
The current earnings forecast score of Elevance Health Inc is 7.42, ranking 41 out of 75 in the Healthcare Providers & Services industry. The average price target is 395.00, with a high of 491.45 and a low of 297.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Elevance Health Inc is 7.38, ranking 16 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 381.50 and the support level at 313.96, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Elevance Health Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 97.95%, representing a quarter-over-quarter increase of 0.93%. The largest institutional shareholder is The Vanguard, holding a total of 22.88M shares, representing 10.30% of shares outstanding, with 5.73% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Elevance Health Inc is 8.65, ranking 6 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.50. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
